These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 9239444

  • 21. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
    Booij J, Andringa G, Rijks LJ, Vermeulen RJ, De Bruin K, Boer GJ, Janssen AG, Van Royen EA.
    Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
    [Abstract] [Full Text] [Related]

  • 22. Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions.
    Laruelle M, Giddings SS, Zea-Ponce Y, Charney DS, Neumeyer JL, Baldwin RM, Innis RB.
    J Neurochem; 1994 Mar; 62(3):978-86. PubMed ID: 8113817
    [Abstract] [Full Text] [Related]

  • 23. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC, Innis RB, Rudnick G.
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [Abstract] [Full Text] [Related]

  • 24. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA, Kuikka JT, Ahonen A, Vanninen E.
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [Abstract] [Full Text] [Related]

  • 25. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP, Laruelle M, van Dyck CH, Wallace E, Baldwin RM, Zoghbi S, Zea-Ponce Y, Neumeyer JL, Charney DS, Hoffer PB, Innis RB.
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM.
    Donnemiller E, Brenneis C, Wissel J, Scherfler C, Poewe W, Riccabona G, Wenning GK.
    Eur J Nucl Med; 2000 Sep; 27(9):1410-4. PubMed ID: 11007526
    [Abstract] [Full Text] [Related]

  • 28. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
    Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, Turk MF, Burnett OL.
    Mov Disord; 1999 Nov; 14(6):940-6. PubMed ID: 10584667
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain.
    Bergström KA, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn CG, Farde L.
    Eur J Nucl Med; 1997 Jun; 24(6):596-601. PubMed ID: 9169564
    [Abstract] [Full Text] [Related]

  • 31. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
    Fischman AJ, Babich JW, Elmaleh DR, Barrow SA, Meltzer P, Hanson RN, Madras BK.
    J Nucl Med; 1997 Jan; 38(1):144-50. PubMed ID: 8998169
    [Abstract] [Full Text] [Related]

  • 32. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study.
    Boesch SM, Donnemiller E, Müller J, Seppi K, Weirich-Schwaiger H, Poewe W, Wenning GK.
    Mov Disord; 2004 Nov; 19(11):1320-5. PubMed ID: 15390003
    [Abstract] [Full Text] [Related]

  • 33. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, Charney DS, van Dyck CH, Hoffer PB, Innis RB.
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.
    Naumann M, Pirker W, Reiners K, Lange KW, Becker G, Brücke T.
    Mov Disord; 1998 Mar; 13(2):319-23. PubMed ID: 9539347
    [Abstract] [Full Text] [Related]

  • 36. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.
    Kim SE, Lee WY, Choe YS, Kim JH.
    Neurol Res; 1999 Apr; 21(3):255-61. PubMed ID: 10319333
    [Abstract] [Full Text] [Related]

  • 37. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT.
    Volkow ND, Gatley SJ, Fowler JS, Chen R, Logan J, Dewey SL, Ding YS, Pappas N, King P, MacGregor RR.
    Synapse; 1995 Mar; 19(3):206-11. PubMed ID: 7784960
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.